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Differentiation of SqCC/Yl, a human malignant squamous 
carcinoma, can be modulated by the presence of both cortico-
steroids and retinoids. To evaluate the regulation of the dif-
ferentiation of epidermal cells by these agents, we have em-
ployed delipidized serum from which glucocorticoids and 
retinoids were removed. Thirty percent of SqCC/Yl cells 
spontaneously expressed the terminally differentiated phe-
notype after 6 d in culture, as measured by the capacity to 
form detergent-insoluble cornified envelopes. Exposure of 
SqCC/Yl cells to hydrocortisone at concentrations of 30, 
100 and 300 nM produced a 25, 100, and 175%, increase, 
respectively, in the number of differentiated cells over un-
treated control cultures. Exposure of cells to retinoic acid at 
levels of from 3 to 300 nM caused a 24 to 85% decrease in the 
quantity of differentiated cells. Simultaneous treatment of 
T he transformation of keratinocytes to the correspond-ing malignant phenotype appears to be associated , with an aberration in the normal response to exoge-nous regulators of terminal differentiation. Thus, ma-lignant squamous epithelia exhibit a decreased capac-
ity to differentiate terminally in response to agents such as calcium 
and phorbol esters, which stimulate the differentiation of their nor-
mal counterpart [1 - 4] . In addition, malignant epithelial cells appear 
to be much more sensitive to agents that inhibit maturation, such as 
epidermal growth factor (EGF) and retinoids [5 - 7]. We have used 
SqCC/Yl, a human malignant squamous cell line derived from a 
carcinoma of the stratified squamous epithelium of the cheek, to 
study the regulation of the terminal differentiation of malignant 
keratinocytes [8,9J. The capacity of epithelial cells to form deter-
gent-insoluble cornified cell envelopes has been used as a marker for 
the terminally differentiated phenotype [10-12]. 
Hydrocortisone has been reported to stimulate the terminal dif-
ferentiation' of squamous carcinoma celis, and retinoids have been 
reported to reverse the effects of hydrocortisone on the formation of 
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SqCC/Yl cells with hydrocortisone and retinoic acid re-
sulted in mutual antagonism of cornified envelope forma-
tion. Treatment of SqCC/Yl cells with a lOOO-fold molar 
excess of retinoic acid did not directly alter the uptake of 
hydrocortisone, and a 100-fold molar excess did not directly 
inhibit the binding of the corticosteroid to its receptor. Pre-
treatment of cells for 48, 72, or 96 h with 100 nM retinoic 
acid decreased the binding of hydrocortisone to its receptor 
by only 20%, and only resulted in a small decrease in the total 
amount of hydrocortisone associated with cells 48 h after the 
addition of retinoic acid. These findings suggest that the 
antagonism between hydrocortisone and retinoic acid on the 
terminal differentiation of SqCC/Yl is not expressed at the 
level of the corticosteroid receptor. ] Invest Dennatol 
93:165-168,1989 
cornified envelopes [6,8,13,14]. In addition, retinoids have been 
shown to exert effects opposite to that of glucocorticoids in other 
systems, such as on the expression of EGF receptors, the growth of 
NHIK 3025 cells in soft agar, transglutaminase activity, and the 
proliferation and morphology of various cultured cells [15 -18]. 
The ability of agents to stimulate or inhibit the differentiation of 
epithelial cells depends on the culture conditions used [13,14,19]. 
The serum used for in vitro studies often contains glucocorticoids 
and retinoids at concentrations that affect the degree of terminal 
differentiation [19]. Thus, we have found inconsistent changes in 
the percentage of differentiated cells in response to glucocorticoids 
and retinoids when cells are cultured in serum-containing medium, 
as the concentration of glucocorticoids and retinoids in serum varies 
with the different batches and manufacturers. To examine the ef-
fects of hydrocortisone and retinoic acid on cellular differentiation 
in a defined system, we have used a solvent extraction method 
developed by Rothblat et al [20], to remove glucocorticoids and 
retinoids from serum. Hence, the amount of hydrocortisone and 
retinoic acid in the tissue culture system can be precisely monitored. 
Using combinations of both agents we have found that hydrocor-
tisone increases and retinoic acid decreases the formation of corni-
fied envelopes. In addition, these two agents antagonize each other 
in a concentration-dependent manner. Because the effects of hydro-
cortisone a.re receptor mediated, it was conceivable that the ob-
served reversal of the stimulatory effects of hydrocortisone pro-
duced by the retinoids was due to a decrease in the amount of 
glucocorticoid binding to its receptor. In the present study, we have 
evaluated in detail the relationship between hydrocortisone and 
retinoic acid in SqCC/YI and have measured the effects of retinoic 
acid on the cellular uptake of the glucocorticoid and the binding of 
the corticosteroid to its receptor. 
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MATERIALS AND METHODS 
Cell Culture SqCCjYl cells grown in monolayer were main-
tained in a medium containing equal volumes of Dulbecco's modi-
fied Eagle's medium and Ham's F-12 medium supplemented with 
10% fetal bovine serum (FBS) (Gibco, Grand Island, NY) and 
20 mM 3-(N-morpholino) propanesulfonic acid buffer (pH 7.35). 
Cells were incubated at 37°C in a humidified atmosphere of95% 
airj5% CO2 and subcultured every 2-3 d, when cells were at ap-
proximately 80% saturation density. In each experiment, cells were 
seeded at a concentration of 1.2 X 106 cells in 25-cm flasks and 
grown to confluence. Cells were then switched to the same medium 
(day 0), with or without drugs, in which FBS was replaced by 
delipidized FBS [20] . Fresh medium containing delipidized serum 
with or without drugs was added on day 3 and cellular differentia-
tion was determined on day 6. Chemicals were purchased from 
Sigma Chemical Co. (St. Louis, MO) unless specified. 
Measurement of Terminal Differentiation Envelope compe-
tent cells were assayed by a slight modification of the procedure of 
Cline and Rice [14]. Cells were washed once with Ca++-free phos-
phate-buffered saline-EDTA (Gibco) and detached from culture 
dishes by treatment with trypsin-EDTA solution (Gibco). An ali-
quot of the cell suspension was removed to determine total cell 
number, and cells in the remaining portion were collected by cen-
trifugation at 1000 g for 5 min. Cells were then resuspended in 1 ml 
of serum-free medium containing 100 11M of the calcium iono-
phore X537 A (Hoffman-LaRoche, Nutley, NJ). After incubation at 
3rc for 2 h, nopenvelope competent cells were lysed by the addi-
tion of 1 ml of 2% sodium dodecyl sulfate and 2% p-mercaptoeth-
anol at room temperature. The number of detergent-insoluble cor-
nified cell envelopes was ascertained using a phase contrast 
microscope; the percentage of envelope-competent cells was con-
sidered to be an expression of the degree of terminal differentiation. 
Cellular Uptake of (3HJHydrocortisone Cells grown in 24 
well dishes for 24 h were washed once with 2 ml of binding me-
dium (Dulbecco's modified Eagle's medium, 1 % bovine serum al-
bumin, and 20 mM HEPES), and then incubated with 25 11M 
pH]hydrocortisone (40 Ci/mmol) for various intervals of time. At 
the end of each time interval, cells were washed 5 times with serum-
free medium supplemented with 1 % bovine serum albumin at 4°C 
60 0 
50 / c 0 0 40 
-c /. Q) .... 30 Q) '+-
'+- /0 ./ 0 20 
~ o e~ 0 
10 0--0---- / 
I--e--e -----
- --- ---------00 12 2 3 4 5 6 
Days 
Figure 1. Effects of hydrocortisone and rctinoic acid on thc differentiation 
of SqCC/Yl carcinoma cells. SqCC/Yl cells were grown in a medium 
consisting of equal parts of Dulbecco's modified Eagle's medium and F-12 
mcdium and 10% FBS in the absence (e) or prcsence of 100 nM hydrocorti-
sone (0) or 30 nM rctinoic acid (II). Thc percentage of cells capable of 
forming cornified envelopes was measured daily. Data represent the mean of 
two separate experimcnts. Samples with percent cnvelope competent cells 
less than 20%, standard deviation :s; ± 2%; less than 50%, standard deviation 
:s; ± 5%; greatcr than 50%, standard deviation :s; ± 10%. 
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and were lysed with 0.4 ml of 1 N NaOH. After neutralization 
with an equal volume of 1 N HCI, the radioactivity of the cell lysate 
was determined with a scintillation spectrometer. In some of the 
experiments, a 1000-fold molar excess of retinoic acid was added 
during the incubation to determine whether the retinoid directly 
interfered with the uptake of hydrocortisone. 
Binding of (3H]Dexamethasone to Cytosolic Glucocorticoid 
Receptors Cells were grown as described above and treated with 
100 nM retinoic acid for various time intervals in medium contain-
ing delipidized serum. Cells were collected by trypsinization and 
resuspended in a hypotonic buffer containing 15 mM Tris-HCl 
(pH 7.4), 0.5 mM EDTA, 10 mM sodium molybdate (Mallinckrodt 
Chemicals, NY), 10 mM dithiothreitol (Bio-Rad, Richmond, CA), 
and 2 mM p-mercaptoethanol (Bio-Rad). After incubation at 4 ° C 
for 30 min, the cells were disrupted by sonication and centrifuged at 
1000 g for 5 min. The cytosolic fraction containing the glucocorti-
coid receptor was collected by centrifugation of the supernatant at 
30,000 g for 30 min. Receptor binding was determined as described 
by McBlain and Shyamala [21]. After incubation with [3H] dexa-
methasone (44 Cijmmol) at 4 °C for 6 h, cytosolic fractions were 
treated with an equal volume of dextran: charcoal solution 
(2%: 2%,v jv) for 10 min at 4°C, and then centrifuged at 11,000 g 
for 2 min. The radioactivity of the supernatant was determined 
with a scintillation spectrometer. Nonspecific binding, measured by 
the addition of a 100-fold excess of unlabeled ligand, was always less 
than 20% of the total binding. Binding parameters were determined 
by Scatchard analysis [22] . 
RESULTS 
SqCCjYl cells attained the capacity to form cornified envelopes 
after they were grown in delipidized serum containing medium (Fig 
1). Increasing the time of incubation increased the number of cells 
that were able to form cornified cellular envelopes. The addition of 
100 nM hydrocortisone caused a further increase in the percentage 
of envelope-competent cells. Thus, exposure to 100 11M hydrocor-
tisone for 6 d resulted in the differentiation of 60% of SqCCjYl 
cells compared with 28% in untreated control cells. In contrast, the 
ability of SqCC/Yl cells to form cornified envelopes was essen-
tially completely abolished by the addition of30 11M retinoic acid to 
the cultures. 
We have previously shown that hydrocortisone partly reverses 
the inhibitory effects of retinoic acid on the terminal differentiation 
of SqCCjYl cells [9]. To further characterize the mutual antago-
nism between hydrocortisone and retinoic acid on the expression of 
the terminally differentiated phenotype, SqCCjYl cells were cul-
tured in the presence of various combinations of the two agents. 
Hydrocortisone increased the percentage of envelope-competent 
cells in a concentration-dependent manner, and almost all of the 
cells attained the ability to form cornified envelopes when they 
were exposed to 300 11M hydrocortisone (Fig 2). In contrast, reti-
noic acid greatly suppressed the maturation ofSqCCjYl cells, even 
in the presence of hydrocortisone. The degree of terminal differen-
tiation that occurred depended on the relative amounts of hydro cor-
tisone and retinoic acid present in the culture medium. 
To determine if the antagonism between hydrocortisone and reti-
noic acid was the result of a decrease in the uptake or the receptor 
binding of the steroid, the cellular association and the receptor 
binding of the glucocorticoid were assayed. Addition of a 1000-fold 
molar excess of retinoic acid simultaneously with PH] hydrocorti-
sone did not directly alter the rate of association of the labeled 
corticosteroid with SqCCjYl cells (Fig 3); however, pretreatment 
with 100 11M retinoic acid for 48 h before the addition of PH] 
hydrocortisone produced a slight but statistically significant de-
crease in the amount of radio labeled hydrocortisone associated with 
the cells (Fig 4). To gain further information on this phenomenon, 
cytosolic receptor was measured by the addition of a saturating 
concentration of PH] dexamethasone to a cytosolic preparation of 
SqCCjYl cells (Fig 5). Dexamethasone was employed in these 
assays, as it has a higher binding affinity than that of hydrocortisone. 
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Figure 2. Differentiation of SqCC/Yl carcinoma cells in the presence of 
variolls concentrations of retinoic acid and hydrocortisone. SqCC/Yl cells 
were grown in the presence of increasing concentrations of hydrocortisone 
alone (e) or hydrocortisone in combination with 3.0 nM (0), 10 nM (II), 
30 nM (0), 100 nM (&), or 300 nM (b.) retinoic acid. The percentage of 
cells capable of forming cornified envelopes was determined 6 d after treat-
ment with drugs. Data represent the mean of three separate experiments. 
Samples with percent envelope competent cells less than 20%, standard 
deviation';; ± 2%; less than 50%, standard deviation';; ± 5%; greater than 
50%, standard deviation';; ± 10%. 
Experiments have been performed to insure that dexamethasone 
and retinoic acid have antagonistic effects on the differentiation of 
SqCC/Yl cells (data not shown). No difference was observed in the 
amount of [3H] dexamethasone bound to the cytosolic receptor 
prepared from cells treated with retinoic acid for 24 h; however, an 
approximately 20% decrease in the binding of the labeled steroid 
occurred in preparations from cells treated with retinoic acid for 48, 
72, or 96 h. Addition of a 100-fold molar excess of retinoic acid 
during the incubation period demonstrated that retinoic acid did not 
directly inhibit the binding of the glucocorticoid to its receptor, 
except at a very high concentration of retinoic acid (Fig 6). Scat-
chard analysis indicated that the decrease in the binding of dexa-
methasone to its receptor in cells pretreated with retinoid, in serum-
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Figure 3. Effects of retinoic acid on the uptake of PH] hydrocortisone by 
SqCC/Yl carcinoma cells. The uptake of PH] hydrocortISone was deter-
mined in the presence (Irf!I) or absence (II) of25 /lM ret1l10lC aCId by method-
ology described in Materials alld Methods. Data are the mean of two separate 
experiments containing triplicate samples ± standard error. 
RETiNOIC ACID AND HYDROCORTISONE ANTAGONISM 167 
'$ 360 
a; 
"'u 
0 
Q; 300 
a 
,[ 
'" 
240 c 
0 
'" 
'" 8 
0 180 
-0 
>-
I 
:r 120 
'0 
'" iii
'u 60 0 
'" 
'" ..:
a; 
u 0 
2 5 15 30 
Time of Exposure to [' H) Hydrocortisone (min) 
Figure 4. Effects of retinoic acid pretreatment on the uptake of [3H] hydro-
cortisone by SqCC/Yl carcinoma cells. SqCC/Yl cells were pretreated 
with (Irf!I) or without (II) 100 nM retinoic acid for 48 h and cell associated 
[3H] hydrocortisone was measured as described in Materials and Methods. Data 
are the mean of four separate experiments containing triplicate samples ± 
standard error (* = p < 0.05). 
free insulin, transferrin, selenium-containing medium, was due to a 
decrease in receptor number rather than a change in the binding 
affinity of the glucocorticoid (data not shown). 
DISCUSSION 
Our laboratory has shown that hydrocortisone increases and reti-
noic acid decreases the terminal differentiation of SqCC/Yl squa-
mous carcinoma cells [8,9]. In addition, we have found that these 
two agents show a concentration-dependent mutual antagonism. 
Because serum-containing medium contains variable amounts of 
glucocorticoids and retinoids, the effects of these agents are best 
quantitated in a tissue culture environment from which serum-asso-
ciated hydrocortisone and retinoic acid are removed. This can be 
achieved by using delipidized serum. Using this system, we have 
found that 25, 100, and 200 nM hydrocortisone are required to 
reverse the inhibitory effects of 10, 30, and 100 nM retinoic acid, 
respectively, on the differentiation of SqCC/Yl cells, to that of the 
control level. These findings indicate that SqCC/Yl carcinoma 
cells are more sensitive on a molar basis to the inhibitory effects of 
180 
C-
'w (5 
Ci.. 150 
0> 
E Q; 
'0 120 I 
'0 
C 
:::l 
0 90 co 
Q) 
c 
0 
Vl 60 ro 
.r: Q) 
E 
ro 
x 30 Q) 
0 
I 
M 
0 
24 48 72 96 
Hours of Pretreatment with Retinoic Acid 
Figure 5. Effects of retinoic acid on the binding of [3H] dexamethasone t~ 
the glucocorticoid receptor. Cytosol was collected from SqCC/Yl carcI-
noma cells pretreated with 100 nM retinoic acid (Irf!I) for vario.us ~ime inter-
vals and compared with untreated control cells (II). GlucocorticoId receptor 
binding was carried out as described in Materials atld Methods. Data are the 
mean of three separate experiments containing triplicate samples ± standard 
error (* = p < 0.05, *. = P < 0.01). 
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Figure 6. Binding of [3H) dexamethasone to cytosolic receptors ofSqCCj 
Yl ce ll s. Cytosol was collected from cells grown in a medium containing 
del ipidized serum. T he binding assay was carried out in a solution containing 
[3H) dexamethasone in the absence (II) or the presence of a 100-fold molar 
excess of unlabeled dexamethasone (II1II) or retinoic acid (~). Data are the 
mean of rwo separate experiments containing trip licate samples ± standard 
error. Bars where standard error is not graphed standard error < 0.75 (* = 
P < 0.05). 
retinoic acid on differentiation than to the stimulatory action of 
hydrocortisone on the m aturation process. 
We have observed a statistically significant decrease in the cellu-
lar uptake of glucocorticoid after cells were treated with 100 nM 
retinoic acid for 48 h . The precise reason for the decrease in the 
uptake of glucocorticoid produced by retinoic acid is unknown, as is 
whether this change is of physiologic significance. It appears that 
this phenomenon is not due to the direct inhibition of the cellular 
uptake of the glucocorticoid by retinoic acid, which has been postu-
lated to enter cells by simple diffusion. 
After entering target cells, steroid hormones bind to receptors to 
exert their effects. Twenty percent lower glucocorticoid binding 
occurred in SqCC/Yl cells treated with 100 nM retinoic acid for 
48 h or longer, which may be responsible for the small decrease in 
the cellul ar uptake of the g lucocorticoid in retinoic acid-treated 
cells. It appears that this phenomenon is not the result of direct 
competition between retinoic acid and the glucocorticoid for the 
corticosteroid binding site. Despite the statistical significance of the 
decrease in corticosteroid uptake and binding to its receptor, it ap-
pears that at best this effect could only be a small part of the antago-
nistic effect between corticosteroids and retinoids on the cellular 
differentiation of epidermal cells, especially because as little as 
10 nM retinoic acid is capable of inhibiting the stimulatory effects 
of hydrocortisone on the m aturation process. 
These findings suggest that the antagonism between hydrocorti-
sone and retinoic acid is mediated by events that occur after the 
corticosteroid binds to its receptor. Alternatively, the antagonism 
may be expressed at the level of the retinoid binding protein. Using 
neoplastic cells derived from human epithelia, Kim et al [5] have 
demonstrated that malignant cells are 10-times more sensitive than 
normal epidermal cell s to the inhibitory effects of retinoids on ter-
minal differentiation. It is tempting to postulate that the process of 
terminal differentiation of epidermal cells is regulated by glucocor-
ticoids, retinoids, and other factors such as EGF under normal con-
ditions, and that neoplastic transformation increases the sensitivity 
of epidermal cells to the regulatory suppressors of terminal differen-
tiation such as retinoids and epidermal growth factor [7], serving to 
maintain these cell s in a proliferative mode. Thus, agents that antag-
onize the effects of retinoic acid on terminal differentiation, such as 
the g lucocorticoids may ultimately be of utility in the treatment of 
various squamous cell carcinomas. 
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